Literature DB >> 20631271

2010 Canadian Hypertension Education Program recommendations: An annual update.

Norm Campbell, Margaret Moy Lum Kwong.   

Abstract

Entities:  

Mesh：

Year:  2010        PMID： 20631271      PMCID： PMC2921891     

Source DB:  PubMed          Journal:  Can Fam Physician        ISSN： 0008-350X            Impact factor:   3.275


× No keyword cloud information.
  30 in total

Review 1.  A systematic review of the effectiveness of promoting lifestyle change in general practice.

Authors:  R Ashenden; C Silagy; D Weller
Journal:  Fam Pract       Date:  1997-04       Impact factor: 2.267

2.  Canadian efforts to prevent and control hypertension.

Authors:  Norman R C Campbell; Guanmin Chen
Journal:  Can J Cardiol       Date:  2010 Aug-Sep       Impact factor: 5.223

3.  The impact of the Canadian Hypertension Education Programme in its first decade.

Authors:  Finlay A McAlister; Ross D Feldman; Katherine Wyard; Rollin Brant; Norman R C Campbell
Journal:  Eur Heart J       Date:  2009-05-19       Impact factor: 29.983

4.  Residual lifetime risk for developing hypertension in middle-aged women and men: The Framingham Heart Study.

Authors:  Ramachandran S Vasan; Alexa Beiser; Sudha Seshadri; Martin G Larson; William B Kannel; Ralph B D'Agostino; Daniel Levy
Journal:  JAMA       Date:  2002-02-27       Impact factor: 56.272

5.  Cost-effectiveness of intensive glycemic control, intensified hypertension control, and serum cholesterol level reduction for type 2 diabetes.

Authors: 
Journal:  JAMA       Date:  2002-05-15       Impact factor: 56.272

6.  Lack of control of high blood pressure and treatment recommendations in Canada.

Authors:  N Khan; A Chockalingam; N R C Campbell
Journal:  Can J Cardiol       Date:  2002-06       Impact factor: 5.223

Review 7.  Worldwide prevalence of hypertension: a systematic review.

Authors:  Patricia M Kearney; Megan Whelton; Kristi Reynolds; Paul K Whelton; Jiang He
Journal:  J Hypertens       Date:  2004-01       Impact factor: 4.844

8.  Effects of dietary sodium reduction on blood pressure in subjects with resistant hypertension: results from a randomized trial.

Authors:  Eduardo Pimenta; Krishna K Gaddam; Suzanne Oparil; Inmaculada Aban; Saima Husain; Louis J Dell'Italia; David A Calhoun
Journal:  Hypertension       Date:  2009-07-20       Impact factor: 10.190

9.  Trends in antihypertensive drug prescriptions and physician visits in Canada between 1996 and 2006.

Authors:  Brenda R Hemmelgarn; Guanmin Chen; Robin Walker; Finlay A McAlister; Hude Quan; Karen Tu; Nadia Khan; Norm Campbell
Journal:  Can J Cardiol       Date:  2008-06       Impact factor: 5.223

10.  The global cost of nonoptimal blood pressure.

Authors:  Thomas A Gaziano; Asaf Bitton; Shuchi Anand; Milton C Weinstein
Journal:  J Hypertens       Date:  2009-07       Impact factor: 4.844
View more
  5 in total

1.  Out-of-office BP measurement vital.

Authors:  David Rapoport
Journal:  Can Fam Physician       Date:  2010-09       Impact factor: 3.275

Review 2.  The Dietary Approaches to Stop Hypertension (DASH) eating pattern in special populations.

Authors:  Crystal C Tyson; Chinazo Nwankwo; Pao-Hwa Lin; Laura P Svetkey
Journal:  Curr Hypertens Rep       Date:  2012-10       Impact factor: 5.369

3.  Feedback GAP: study protocol for a cluster-randomized trial of goal setting and action plans to increase the effectiveness of audit and feedback interventions in primary care.

Authors:  Noah M Ivers; Karen Tu; Jill Francis; Jan Barnsley; Baiju Shah; Ross Upshur; Alex Kiss; Jeremy M Grimshaw; Merrick Zwarenstein
Journal:  Implement Sci       Date:  2010-12-17       Impact factor: 7.327

4.  Feedback GAP: pragmatic, cluster-randomized trial of goal setting and action plans to increase the effectiveness of audit and feedback interventions in primary care.

Authors:  Noah M Ivers; Karen Tu; Jacqueline Young; Jill J Francis; Jan Barnsley; Baiju R Shah; Ross E Upshur; Rahim Moineddin; Jeremy M Grimshaw; Merrick Zwarenstein
Journal:  Implement Sci       Date:  2013-12-17       Impact factor: 7.327

5.  Assessment of glomerular filtration rate based on alterations of serum brain-derived neurotrophic factor in type 2 diabetic subjects treated with amlodipine/benazepril or valsartan/hydrochlorothiazide.

Authors:  I-Te Lee; Wayne Huey-Herng Sheu; Yi-Jen Hung; Jung-Fu Chen; Chih-Yuan Wang; Wen-Jane Lee
Journal:  Dis Markers       Date:  2015-03-30       Impact factor: 3.434
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.